IADR Abstract Archives

Bisphosphonate-related Alterations in Mandibular Condyle Growth: A Histomorphometric Study

The use of bisphosphonates (Bphs) in pediatric patients with metabolic bone diseases is still under study. Previous works performed at our laboratory showed that alendronate (ALN) decreased the downward forward growth of the mandible as measured from the condyle. 

Objective:  to histologically and histomorphometrically evaluate the effect of ALN on the mandibular condyle of healthy growing animals. 

Methods:  healthy male Wistar rats weighing 82±7 g and aged 30 days were divided into two groups (n=4): ALN, receiving a 0.3 mg/kg/body weight weekly i.p. dose of ALN; and Sham (Sh): receiving vehicle. After 8 weeks-treatment, the animals were anesthetized and blood samples were obtained to determine calcemia (Ca), phosphatemia (PH) and total alkaline phosphatase (TAP). Following euthanasia, the hemimandibles were resected and processed histologically to obtain histological cross-sections, which were stained with: 1) H&E and 2) PAS. The following histomorphometric parameters were measured on digitalized microphotographs of both condyles: 1) number of osteoclasts per mm (N.Oc/mm), number of blood vessels (N.Bv/mm2), and volume occupied by the vessels (BvV/MV)(%); 2) trabecular volume (TbV/TV)(%), and bone tissue (BV/TbV)(%) and cartilage tissue volumes (CV/TbV)(%). The results were statistically analyzed using Student’s test; a value of p<0.05 was considered statistically significant.

Results:  there were no significant differences in serum determinations between groups. N.Oc/mm: Sh 0.84±0.20, ALN 1.69±0.35, p<0.01; N.Bv/MV(vessels/mm2): Sh 104.81±20.9, ALN 107.9±25.5, NS; BvV/MV(%): Sh 17.8±6.3, ALN 19.0±5.0, NS; TbV/TV(%): Sh 52.9±3.4, ALN 63.6 ± 0.9, p<0.001; BV/TbV(%): Sh 77.1±5.1, ALN 55.22±7.38, p<0.01; CV/TbV(%): Sh 22.9±5.1, ALN 44.78±7.38, p<0.01. Giant osteoclasts exhibiting apoptotic morphology were observed in the ALN group. 

Conclusion: the present study shows that the ALN-related osteoclast dysfunction alters endochondral ossification at the level of the mandibular condyle. This finding should be taken into account when treating growing patients who take bisphosphonates.

Division: IADR/AMER General Session
Meeting: 2014 IADR/AMER General Session (Cape Town, South Africa)
Location: Cape Town, South Africa
Year: 2014
Final Presentation ID: 883
Abstract Category|Abstract Category(s): IADR/Unilever Hatton Awards
Authors
  • Oyhanart, Sharon  ( School of Dentistry, University of Buenos Aires, Buenos Aires, , Argentina )
  • Escudero, Natalia  ( School of Dentistry, University of Buenos Aires, Buenos Aires, , Argentina )
  • Mandalunis, Patricia  ( School of Dentistry, University of Buenos Aires, Buenos Aires, , Argentina )
  • SESSION INFORMATION
    Poster Session
    Senior-Basic Science
    06/27/2014